Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Ethereum could turn $5,000 into $57,400 by 2028, outperforming XRP's $44,300 potential return.

Market News
17 May 2026
24/7 Wall Street
View Source
Bullish
pluang ai news

A $5,000 investment in Ethereum today could grow to about $57,400 by 2028, based on a price target of $25,000 per ETH, while the same amount in XRP might reach $44,300 if XRP hits $12.50. XRP's growth is supported by Ripple's expanding payment network and easing regulatory pressures, but it still faces challenges to reach its forecast. Ethereum benefits from strong institutional accumulation, upcoming network upgrades, and expanding blockchain use, making it a more robust long-term investment. Investors should weigh XRP's potential surprises against Ethereum's steady growth path.

More News

Diraq appoints Scott A. McGregor as chairman to lead US expansion of silicon-based quantum computing.

Diraq appoints Scott A. McGregor as chairman to lead US expansion of silicon-based quantum computing.

Diraq, a pioneer in silicon-based quantum computing, has appointed Scott A. McGregor, former Broadcom CEO, as Chairman of the Board to support its US expansion and product launch by 2029. McGregor's semiconductor expertise aligns with Diraq's goal to...

Company Fundamentals
Bullish
31 minutes ago
Jet fuel price surge adds $100B cost, pushing airlines toward crisis with profits halving in 2026.

Jet fuel price surge adds $100B cost, pushing airlines toward crisis with profits halving in 2026.

The global airline industry faces a $100 billion increase in jet fuel costs due to a Middle East conflict, threatening its post-pandemic recovery. Fuel prices surged over 100% in March, forcing airlines to cut less profitable routes and causing major...

Market News
Bearish
1 hour ago
Pfizer's obesity drug berobenatide shows 16% weight loss in Phase 2b trial, Phase 3 enrollment open

Pfizer's obesity drug berobenatide shows 16% weight loss in Phase 2b trial, Phase 3 enrollment open

Pfizer reported that its obesity drug berobenatide achieved a 15.9% weight loss in a Phase 2b study without placebo adjustment. The pivotal Phase 3 trial for berobenatide is now open for enrollment, aiming to strengthen Pfizer's position in obesity t...

Company Fundamentals
Bullish
1 hour ago
GE Aerospace partners with Wolfspeed to develop high-voltage silicon carbide power modules amid mixed stock performance.

GE Aerospace partners with Wolfspeed to develop high-voltage silicon carbide power modules amid mixed stock performance.

GE Aerospace announced a collaboration with Wolfspeed to develop high-voltage silicon carbide power modules, aiming to enhance efficiency in aerospace and defense sectors. This partnership aligns with U.S. government priorities to accelerate critical...

Market News
Neutral
1 hour ago
Sportradar stock jumps 9.5% on new global partnership with Kalshi prediction market.

Sportradar stock jumps 9.5% on new global partnership with Kalshi prediction market.

Sportradar shares rose sharply after announcing a multi-year global partnership with Kalshi, the world's largest prediction market. This deal expands Sportradar's role as a key data provider across major sports leagues like MLB and NHL, enhancing tra...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App